- Home
- GLPG vs DBRG Comparison
GLPG vs DBRG Comparison
Compare GLPG & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- DBRG
- Stock Information
- Founded
- GLPG 1999
- DBRG 1991
- Country
- GLPG Belgium
- DBRG United States
- Employees
- GLPG N/A
- DBRG N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- DBRG Real Estate Investment Trusts
- Sector
- GLPG Health Care
- DBRG Real Estate
- Exchange
- GLPG Nasdaq
- DBRG Nasdaq
- Market Cap
- GLPG 1.8B
- DBRG 1.5B
- IPO Year
- GLPG 2005
- DBRG 2009
- Fundamental
- Price
- GLPG $26.86
- DBRG $11.85
- Analyst Decision
- GLPG Sell
- DBRG Strong Buy
- Analyst Count
- GLPG 4
- DBRG 9
- Target Price
- GLPG $25.33
- DBRG $15.94
- AVG Volume (30 Days)
- GLPG 489.3K
- DBRG 2.7M
- Earning Date
- GLPG 04-23-2025
- DBRG 05-01-2025
- Dividend Yield
- GLPG N/A
- DBRG 0.34%
- EPS Growth
- GLPG N/A
- DBRG N/A
- EPS
- GLPG N/A
- DBRG 0.32
- Revenue
- GLPG $311,493,731.00
- DBRG $566,324,000.00
- Revenue This Year
- GLPG $0.78
- DBRG N/A
- Revenue Next Year
- GLPG N/A
- DBRG $14.09
- P/E Ratio
- GLPG N/A
- DBRG $36.85
- Revenue Growth
- GLPG 18.32
- DBRG N/A
- 52 Week Low
- GLPG $22.36
- DBRG $6.41
- 52 Week High
- GLPG $31.23
- DBRG $17.33
- Technical
- Relative Strength Index (RSI)
- GLPG 58.65
- DBRG 80.36
- Support Level
- GLPG $24.74
- DBRG $8.98
- Resistance Level
- GLPG $27.81
- DBRG $9.32
- Average True Range (ATR)
- GLPG 0.78
- DBRG 0.53
- MACD
- GLPG 0.00
- DBRG 0.29
- Stochastic Oscillator
- GLPG 69.06
- DBRG 96.91
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About DBRG DigitalBridge Group Inc.
DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.